The upswing in the EU economy looks like it's having a positive effect on sales. The last earnings report was better than I expected. My breakeven is about 13. Growth may accelerate in 2014, then it goes back to $20.
I think there may be some downside risk due to interest rate headwinds and near term government shutdown, but if the economy picks up, this stock should easily provide excellent returns. Insiders have been consistent buyers. There's been a little M&A action in the hotel reit sector. I bought a small starter position.
Looks like that new product is rolling out the door. Trading around 1x book and a slight premium to Net Current assets. So was this a one time or once per year type delivery or is this cash flow ongoing quarterly? If the latter, the stock price should be around $12.
it's always a good time to re-evaluate when things happen "for no reason whatsoever." Large insider purchases; they own 11%. Stabilized slow growth, improving CA finances. Impressive cash flow. Control value in contracts. Small cap range bound stock stuck with public company expenses with large well-capitalized competitors, such as Tetra Tech and AECOM. It's worth a gamble below $4.
Not much information from this CC. California counties continue to recover slowly and are hiring additional outsourced staff. SCE Energy segment contracts dribbling in: $4,000,000. Speed rail maybe moving dirt in Dec -- IMO, may be delayed again due to the route change. Over all it was about as I expected, 11 cents vs 11 cents. Q4 quarter guidance: "we expect to be profitable". Q4 2012 was 4 cents -- maybe an easy beat IMO as energy contracts add to the bottom line. Q4 2012 operating cash flow was 5M. If it can be matched this Q4 then all of 2013 cash flow would be $12M. Maybe there was a timing issue that brought some Q4 cash flow into Q3, I don't know. But even if Q4 op cash flow is only $3M, geesh, that would be $10M this year for a company with little capex and no debt. Book value is $2.59 and cash per share is $1.40.
I don't think I've ever seen a biotech abandon an equity sale agreement. If Northera is approved, CHTP will need cash to market. Partnership in the works?
Yeah, they navigated the plummet in refi pretty well, but ask yourself how they are going to grow deposits? IMO, interest rates are going back down. There's no inflation. Economic growth is anemic. They might add a few pennies per share every quarter and the stock might go back to $9, but how can this bank grow?
It appears that it will be revenue positive next year, which is kind of amazing for a young biotech. Now that the FDA has made a negative statement, future catalysts seem on the positive side. I bought a few shares.
Sentiment: Strong Buy
When I invested in this stock, coal was in free fall, and in many ways it still is. But CNX has a lot of attractive assets: cheap coal and natural gas. This could go a lot higher.
Fresno to Tulare segment up for bid. Due Dec 6. "Those making the short list will be selected based on experience, technical competency, ability to perform and other factors, it says. The shortlisted firms will then be eligible to submit formal design-build proposals in 2014." Contract value estimate: $1.5-2 billion. See the Central Valley Business Times web site.
I wondered the same thing myself. Why bother with vague corporate blogging? Either they landed a huge account, in which case they need to issue a PR, or they didn't.
The $5.85 buy turned out to be excellently timed. Now the stock is moving UP during a government shutdown. Odd for a government contractor. Oh well, you never know, right? The reason, if it matters, is debt reduction and cash flow. I'll evaluate the position after the big rally post government restart, sometime in October or November. Merry Christmas!
I had bought around 80 then 70 then 60 then 50 then 40 then 30. Overall it was heavily weighted in the forties. The profit looks good to me. Time to deploy capital elsewhere. Good luck
I neglected to mention that I'm holding based on AFOP's big run. But AFOP isn't worth that either.
It's not worth 14.76 unless it's acquired or they announce some big revenue source. I'm holding based on inside buys only,
True, the effect is short lived. However, Midodrine also demonstrates poor durability. Educate yourself about the disease. Moving from medication to medication is quite common among patients. There is no cure for this. The FDA knows it. The best we can do is hit it with several drugs.
There was a change in management recently. They sold the cooler business. I wouldn't be surprised if the filter business was also sold. Now would be a good time because the pipe business is booming, but it requires more capital. Maybe they can cash in on the joint venture. The big question: how permanent is the new pipe business. If it is permanent, then raise capital through debt. If not, then raise through equity or sell the business. In the past they raised through equity and it showed in the performance of the business and the stock. The orders appear to be substantial, though temporary, a Saudi project here and there. Very finite. I'm going to take a wait and see approach.
Perfect example of buying a decent business with a margin of error. Now earnings look very good. Guidance isn't great, but it was certainly worth more 3.98 per share.